Alzheimer's Disease Pathogenesis
暂无分享,去创建一个
[1] B. Yankner. Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.
[2] S. Lipton,et al. Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.
[3] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[4] H. Loetscher,et al. The Influence of Endoproteolytic Processing of Familial Alzheimer's Disease Presenilin 2 on Aβ42 Amyloid Peptide Formation* , 1999, The Journal of Biological Chemistry.
[5] D. Allsop,et al. The occult aftermath of boxing. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[6] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[7] R. Katzman.,et al. Alzheimer Disease: Basic and Clinical Advances , 1991, Journal of the American Geriatrics Society.
[8] A. Guterman,et al. Neurological Sequelae of Boxing , 1987, Sports medicine.
[9] Y. Tu,et al. Effect of ganglioside GM3 on the activity and conformation of reconstituted Ca2+‐ATPase , 1996, FEBS letters.
[10] M. Mattson,et al. Presenilin-1 Mutation Increases Neuronal Vulnerability to Focal Ischemia In Vivo and to Hypoxia and Glucose Deprivation in Cell Culture: Involvement of Perturbed Calcium Homeostasis , 2000, The Journal of Neuroscience.
[11] R. Katzman.,et al. Advances in Alzheimer's disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] L. Lue,et al. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. , 1996, Journal of neuropathology and experimental neurology.
[13] D. Harman,et al. Free radical theory of aging: Alzheimer’s disease pathogenesis , 1995, AGE.
[14] S. Orrenius,et al. Role of calcium in toxic and programmed cell death. , 1991, Advances in experimental medicine and biology.
[15] S. Sorbi,et al. Alteration of acylphosphatase levels in familial Alzheimer's disease fibroblasts with presenilin gene mutations , 1996, Neuroscience Letters.
[16] M. Mattson,et al. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. , 2008, Journal of neurochemistry.
[17] C. W. Adams,et al. The cerebral vasculature in dementia pugilistica. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[18] K. Beyreuther,et al. Prospects for pharmacological intervention in Alzheimer disease. , 2000, Archives of neurology.
[19] J. Stamler,et al. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. , 1998, Science.
[20] S. Perry,et al. Sites on the cytoplasmic region of phospholamban involved in interaction with the calcium-activated ATPase of the sarcoplasmic reticulum. , 1999, European journal of biochemistry.
[21] R. Martins,et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.
[22] S. Schuchmann,et al. Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down's syndrome. , 2000, Free radical biology & medicine.
[23] N. Larsson,et al. Revolution in mitochondrial medicine , 1999, FEBS letters.
[24] M. Goedert,et al. Risky apolipoprotein in brain , 1994, Nature.
[25] Michael J. Berridge,et al. Inositol phosphates and cell signalling , 1989, Nature.
[26] B. Yankner. New clues to Alzheimer's disease: unraveling the roles of amyloid and tau. , 1996, Nature medicine.
[27] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] Richard J. Miller. The control of neuronal Ca2+ homeostasis , 1991, Progress in Neurobiology.
[29] D. Harman. Alzheimer's Disease: Role of Aging in Pathogenesis , 2002, Annals of the New York Academy of Sciences.
[30] N Howell,et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Selkoe,et al. The Transmembrane Aspartates in Presenilin 1 and 2 Are Obligatory for γ-Secretase Activity and Amyloid β-Protein Generation* , 2000, The Journal of Biological Chemistry.
[32] D. Mann,et al. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.
[33] D. Harman. Alzheimer’s disease: A hypothesis on pathogenesis , 2000, Journal of the American Aging Association.
[34] J. East,et al. An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban. , 1996, The Biochemical journal.
[35] A. Roses,et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.
[36] D. Wallace,et al. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. , 1996, American journal of medical genetics.
[37] E. Storey,et al. The amyloid precursor protein of Alzheimer's disease is found on the surface of static but not actively motile portions of neurites , 1996, Brain Research.
[38] D. Alkon,et al. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] D. Harman. Aging: Prospects for further increases in the functional life span , 1994, AGE.
[40] L. Wolfson,et al. Clinico‐pathologic studies in dementia , 1988, Neurology.
[41] D. Graham,et al. βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.
[42] T. Ozawa. Mitochondrial DNA Mutations and Age , 1998, Annals of the New York Academy of Sciences.
[43] J. Mocco,et al. Dehydroascorbic acid, a blood–brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Goldman,et al. Oxidative stress up‐regulates IL‐8 and TNF‐α synthesis by human dendritic cells , 1998, European journal of immunology.
[45] J. Blass,et al. Systemic manifestations of Alzheimer’s disease , 1988, AGE.
[46] C Oliver,et al. Down's Syndrome and Alzheimer's disease: a review , 1986, Psychological Medicine.
[47] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[48] D. Maclennan,et al. Phospholamban Regulates the Ca2+-ATPase through Intramembrane Interactions* , 1996, The Journal of Biological Chemistry.
[49] D. Harman. Aging: Phenomena and Theories , 1998, Annals of the New York Academy of Sciences.
[50] D. Blacker,et al. The genetics of Alzheimer disease: current status and future prospects. , 1998, Archives of neurology.
[51] K. Beyreuther,et al. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.
[52] R. Schlapbach,et al. Oxidants in mitochondria: from physiology to diseases. , 1995, Biochimica et biophysica acta.
[53] P. Fraser,et al. The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-Catenin* , 1998, The Journal of Biological Chemistry.
[54] David L. Stokes,et al. Structure of the calcium pump from sarcoplasmic reticulum at 8-Å resolution , 1998, Nature.
[55] T D Koepsell,et al. The association between head trauma and Alzheimer's disease. , 1990, American journal of epidemiology.
[56] D. Harman. Free Radical Theory of Aging: Increasing the Average Life Expectancy at Birth and the Maximum Life Span , 1999 .
[57] Bing-sheng Li,et al. α-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway , 2001, Neuroscience Letters.
[58] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[59] A. Zahradníková,et al. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide , 1996, FEBS letters.
[60] J. Weber,et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.
[61] R. S. Sohal,et al. Hydrogen peroxide release by mitochondria increases during aging , 1991, Mechanisms of Ageing and Development.
[62] M. Mattson,et al. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[63] W. Kühlbrandt,et al. Three-dimensional map of the plasma membrane H+-ATPase in the open conformation , 1998, Nature.
[64] E M Wijsman,et al. A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.
[65] K. Kosik,et al. Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.
[66] D. Dickson,et al. The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.
[67] D. Selkoe,et al. Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.
[68] D. Selkoe. Alzheimer's disease: genotypes, phenotypes, and treatments. , 1997, Science.
[69] E. Masliah,et al. Structural basis of the cognitive alterations in Alzheimer disease. , 1994 .
[70] S. Orrenius,et al. Cytoskeletal alterations in human platelets exposed to oxidative stress are mediated by oxidative and Ca2+-dependent mechanisms. , 1989, Archives of biochemistry and biophysics.
[71] D. Harman. Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.
[72] D. Harman. Free radical theory of aging: history. , 1992, EXS.
[73] G. Barja. Mitochondrial Oxygen Radical Generation and Leak: Sites of Production in States 4 and 3, Organ Specificity, and Relation to Aging and Longevity , 1999, Journal of bioenergetics and biomembranes.
[74] Bradley T. Hyman,et al. Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.
[75] N. Green,et al. The Mechanism of Ca 2 1 Transport by Sarco ( Endo ) plasmic Reticulum Ca 2 1-ATPases * , 1997 .
[76] S. Dimauro,et al. Mitochondrial involvement in Alzheimer's disease. , 1999, Biochimica et biophysica acta.
[77] Y. Wang,et al. Antagonistic effect of ganglioside GM1 and GM3 on the activity and conformation of sarcoplasmic reticulum Ca2+‐ATPase , 1999, FEBS letters.
[78] N. Green,et al. The Mechanism of Ca2+ Transport by Sarco(Endo)plasmic Reticulum Ca2+-ATPases* , 1997, The Journal of Biological Chemistry.
[79] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[80] B. Yankner,et al. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.